Selective Intracellular Delivery of Antibodies in Cancer Cells with Nanocarriers Sensing Endo/Lysosomal Enzymatic Activity.
Pengwen ChenWenqian YangYuki MochidaShangwei LiTaehun HongHiroaki KinohKazunori KataokaHoracio CabralPublished in: Angewandte Chemie (International ed. in English) (2024)
The differential enzymatic activity in the endo/lysosomes of particular cells could trigger targeted endosomal escape functions, enabling selective intracellular protein delivery. However, this strategy may be jeopardized due to protein degradation during endosomal trafficking. Herein, using custom made fluorescent probes to assess the endosomal activity of cathepsin B (CTSB) and protein degradation, we found that certain cancer cells with hyperacidified endosomes grant a spatiotemporal window where CTSB activity surpass protein digestion. This inspired the engineering of antibody-loaded polymeric nanocarriers having CTSB-activatable endosomal escape ability. The nanocarriers selectively escaped from the endo/lysosomes in the cells with high endosomal CTSB activity and delivered active antibodies to intracellular targets. This study provides a viable strategy for cell-specific protein delivery using stimuli-responsive nanocarriers with controlled endosomal escape.
Keyphrases
- drug delivery
- cancer therapy
- protein protein
- induced apoptosis
- drug release
- amino acid
- binding protein
- small molecule
- hydrogen peroxide
- reactive oxygen species
- mesenchymal stem cells
- cell death
- cell proliferation
- nitric oxide
- quantum dots
- endoplasmic reticulum stress
- signaling pathway
- single molecule
- oxidative stress